News

The 6th "Ubiquitin & Friends symposium" will take place in Vienna on 20 and 21 May 2019. Information on programme, speakers and registration is now...

Read more

The IMP has launched a new series of audio portraits, podcast-like interviews with group leaders, called "gl'IMPses of Research". In the first...

Read more

Valneva announced positive initial booster data and final Phase 1 data for its leading, unique Lyme disease vaccine candidate VLA15. To investigate...

Read more

On January 26th 2019, the scientific community from Austria (and abroad) got together in the glamorous setting of the Vienna City Hall for the 5th...

Read more

Take advantage of the possibility to get selected VBCF services for free! The open access is supported by the project RIAT-CZ, programme INTERREG V-A...

Read more

The European Union has awarded 10 million Euros to a consortium of 18 research groups that work with mass spectrometry-based proteomics, including the...

Read more

The IMP is sad to share the news of the sudden and untimely passing of Andreas Weith who was a Group Leader at the IMP from 1990 to 1997.

Read more

It is our pleasure to invite you to the official opening of our new Electron Microscope (Glacios) and an Open House of the EM Facility:

 

This Friday...

Read more

Valneva announced the signing of a new $59 million contract with the U.S. government Department of Defense for the supply of its Japanese encephalitis...

Read more

Valneva confirmed its revenue and product sales guidance for 2018 and provided initial product sales guidance for 2019.

Read more

Phase 1 interim results showed an excellent immunogenicity profile after a single-shot vaccination and an acceptable safety profile, supporting...

Read more

Ares Genetics to start EUR 1.3 million TRIPLE-A development project co-funded by Vienna Business Agency, and initiates set-up of R&D and service...

Read more